Cell and gene therapy is changing the way we treat serious diseases like cancer, using gene-edited cells to target illness in ways that weren’t possible before. But behind the scenes, making these therapies isn’t easy. One of the biggest challenges is meeting the complex web of global regulations and safety standards that ensure treatments are safe, consistent, and effective.
At the heart of it all is the quality of the raw materials. Every ingredient—and every supplier—needs to meet strict criteria. Without that, a therapy can’t move forward.
In this eBook, ACROBiosystems digs into the details of what it takes to meet these global standards. You’ll learn about the importance of aseptic processes, rigorous quality control, supply chain transparency, and customs compliance.
The eBook also explains how ACRO’s raw materials and quality systems are built to align with current Good Manufacturing Practice (GMP) guidelines—and how they keep pace with evolving regulations around the world.
Want to know what goes into GMP-grade raw materials? Download ACRO’s eBook to see how its products and support is helping to make cell and gene therapies a clinical reality.
Download the eBook
About ACROBiosystems
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Their mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. They supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, ACROBiosystems delivers solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. ACROBiosystems empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.